Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

9.10
Delayed Data
As of May 27
 +0.05 / +0.55%
Today’s Change
5.57
Today|||52-Week Range
10.95
-15.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues711.0K33.8M31.6M0.00
 
 
 
 
Depreciation And Amortization161.0K184.0K189.0K192.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------192.0K
 
 
General Expenses29.9M16.9M15.0M18.6M
 
 
 
 
 
Research And Development20.0M12.2M9.8M13.3M
 
 
 
 
 
Total Operating Expenses30.1M17.1M15.2M18.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.4M16.7M16.4M-18.8M
 
 
 
 
 
Interest Expense On Debt15.0K12.0K13.0K15.0K
 
 
 
 
 
Other Expenses0.008.9M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.2M26.0M16.8M-18.1M
 
 
 
 
 
Income Taxes-185.0K-245.0K-140.0K-65.0K
 
 
 
 
 
Net Income-29.0M26.3M17.0M-18.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS117.8M136.4M136.6M136.6M
 
 
 
 
 
Shares To Calculate EPS Diluted117.8M140.0M140.5M136.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25$0.19$0.12-$0.13
 
 
 
 
 
EPS Diluted-$0.25$0.19$0.12-$0.13